Tomocube Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
04:32
Jan 06
Tomocube microscope enables organoid testing.
Tomocube's 3D holographic microscope is optimized for organoid analysis, allowing label-free, non-destructive observation that can replace animal testing; global top-tier pharma are early adopters, and the technology has optionality in semiconductor glass substrate inspection, though that business is not yet mass-producing.
MED
03:33
Jan 06
Tomocube offers organoid analysis optionality
Tomocube's holographic microscope analyzes organoids without cutting or staining, is being adopted by global pharma, and has optionality in glass-substrate inspection though not yet mass produced.
Tomocube
MED

About Tomocube Investor Commentary

Across the available history and selected sources, Buzzberg tracks Tomocube across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 50% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: Noh Young-rae.